. . . . . . . . . "The most commonly reported diagnosis treated was Major Depressive Disorder (72.2%), followed by Bipolar Disorder (15.1%), and Posttraumatic Stress Disorder (5.7%). Most providers (87.7%) reported administering ketamine via an intravenous route, with a minority reporting using an oral (22.8%) or an intranasal (19.3%) formulation." . . . . . . "Adults" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "WH66EBsnd4zOO1bx41pXZ3m1X0NAuyd8VYukTK7n1HS6FwCiSvgUCH9SHtB+1kg8sD+PpaZsalHT45SZNno4GqaEkTfCl6vkKZ2Uu7hmZO/rMqsKPaFwF3Oo9HStTeswegs06TyzPgaPwzfVhoznPmBfhPgfxRQ6+8vXpbQ+9+E=" . . "2021-05-25T14:42:02.095+02:00"^^ . . . . .